In last trading session, LifeStance Health Group Inc. (NASDAQ:LFST) saw 1.7 million shares changing hands with its beta currently measuring 0. Company’s recent per share price level of $8.56 trading at -$1.36 or -13.71% at ring of the bell on the day assigns it a market valuation of $3.13B. That closing price of LFST’s stock is at a discount of -248.25% from its 52-week high price of $29.81 and is indicating a premium of 10.75% from its 52-week low price of $7.64. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.73 million shares which gives us an average trading volume of 1.08 million if we extend that period to 3-months.
For LifeStance Health Group Inc. (LFST), analysts’ consensus is at an average recommendation of an Overweight while assigning it a mean rating of 2.10. Splitting up the data highlights that, out of 7 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 3 suggested the stock as a Hold whereas 4 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -$0.21 in the current quarter.
LifeStance Health Group Inc. (NASDAQ:LFST) trade information
Upright in the red during last session for losing -13.71%, in the last five days LFST remained trading in the red while hitting it’s week-highest on Tuesday, 01/11/22 when the stock touched $8.56 price level, adding 20.52% to its value on the day. LifeStance Health Group Inc.’s shares saw a change of -10.08% in year-to-date performance and have moved -6.04% in past 5-day. LifeStance Health Group Inc. (NASDAQ:LFST) showed a performance of -11.11% in past 30-days. Number of shares sold short was 4.94 million shares which calculate 3.23 days to cover the short interests.
LifeStance Health Group Inc. (LFST) estimates and forecasts
6 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of $191.69 million for the same. And 6 analysts are in estimates of company making revenue of $205.01 million in the next quarter that will end on Mar 2022.
LifeStance Health Group Inc. is more likely to be releasing its next quarterly report on November 08 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
LifeStance Health Group Inc. (NASDAQ:LFST)’s Major holders
Insiders are in possession of 15.60% of company’s total shares while institution are holding 78.59 percent of that, with stock having share float percentage of 93.11%. Investors also watch the number of corporate investors in a company very closely, which is 78.59% institutions for LifeStance Health Group Inc. that are currently holding shares of the company. Tpg Group Holdings (sbs) Advisors, Inc. is the top institutional holder at LFST for having 175.28 million shares of worth $2.54 billion. And as of Sep 29, 2021, it was holding 46.85% of the company’s outstanding shares.
The second largest institutional holder is Summit Partners, L.P., which was holding about 45.73 million shares on Sep 29, 2021. The number of shares represents firm’s hold over 12.22% of outstanding shares, having a total worth of $663.15 million.
On the other hand, Fidelity Advisor Growth Opportunities Fund and Fidelity Select Portfolios – Medical Technology & Devices Port are the top two Mutual Funds which own company’s shares. As of Oct 30, 2021, the former fund manager was holding 10.42 million shares of worth $124.88 million or 2.79% of the total outstanding shares. The later fund manager was in possession of 2.1 million shares on Oct 30, 2021, making its stake of worth around $25.16 million in the company or a holder of 0.56% of company’s stock.